Femara 2.5 mg Film Coated Tablet *

  • Company:

    Novartis Ireland Limited
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 20 August 2021

File name

IPHA Femara REGPIL PF 20-0131_Jan_2021_Clean_1629451769.pdf

Reasons for updating

  • Correction of spelling/typing errors

Updated on 25 February 2021

File name

IPHA Femera REGPIL PF 20-0131-Clean Feb 2021 (003)_1614275366.pdf

Reasons for updating

  • Change to section 2 - excipient warnings

Updated on 25 February 2021

File name

Femara REGSPC PF 20-0131 Clean Feb 2021_1614275160.pdf

Reasons for updating

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.4 - Special warnings and precautions for use

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 12 May 2020

File name

IPHA Femara2.5mgFilCoatedTablets_REGPIL_Clean Jan 2020_1589272859.pdf

Reasons for updating

  • Change to section 6 - manufacturer

Updated on 27 November 2019

File name

IPHA_Femara2.5mgFilCoatedTablets_PIL PF19-0205 Nov 2019_Clean_1574864960.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects

Updated on 27 November 2019

File name

Femara REGSPC PF 19-0205 October 2019_Clean_1574863549.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 09 May 2019

File name

Femara 2.5mg FCT 2220784_IE_p2_LFT_X-4 RA reviewed 04.03.2019_IPHA_1557398878.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions

Updated on 22 March 2019

File name

Femara 2.5mg FCT 2214529_IE_p2_LFT_X-4 RA approved 23.08.2018 IPHA_1548158192.pdf

Reasons for updating

  • Change to section 4 - how to report a side effect

Updated on 22 January 2019

File name

Femara 2.5mg FCT 2214529_IE_p2_LFT_X-4 RA approved 23.08.2018 IPHA_1548158192.pdf

Reasons for updating

  • Change to section 6 - marketing authorisation holder

Updated on 24 July 2018

File name

Femara REGSPC_Clean July 2018.pdf

Reasons for updating

  • Change to MA holder contact details

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 24 July 2018

File name

Femara REGSPC_Clean July 2018.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 03 September 2015

File name

PIL_8509_495.pdf

Reasons for updating

  • New PIL for new product

Updated on 03 September 2015

Reasons for updating

  • Addition of information on reporting a side effect.

Updated on 23 April 2014

Reasons for updating

  • Change to warnings or special precautions for use

Updated on 21 December 2012

Reasons for updating

  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to how the medicine works

Updated on 14 April 2009

Reasons for updating

  • Change to information about pregnancy or lactation
  • Change to side-effects

Updated on 05 September 2008

Reasons for updating

  • Change to warnings or special precautions for use
  • Change of contraindications

Updated on 30 January 2007

Reasons for updating

  • Change due to harmonisation of patient information leaflet

Updated on 29 August 2006

Reasons for updating

  • Change to, or new use for medicine

Updated on 16 May 2005

Reasons for updating

  • Change to, or new use for medicine

Updated on 25 August 2004

Reasons for updating

  • New PIL for medicines.ie